scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P2093 | author name string | Moon Young Kim | |
Soon Koo Baik | |||
Gaeun Kim | |||
P2860 | cites work | Assessment for Risk of Bias in Systematic Reviews and Meta-Analyses in the Field of Hepatology | Q26778786 |
Mesenchymal stem cell therapy for liver fibrosis | Q26782128 | ||
Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis | Q26783606 | ||
The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic review | Q26996085 | ||
Overview and recent trends of systematic reviews and meta-analyses in hepatology | Q30434752 | ||
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension | Q30439743 | ||
Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. | Q31090448 | ||
The need for histological subclassification of cirrhosis: a systematic review and meta-analysis | Q35714587 | ||
Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review | Q37781840 | ||
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. | Q41337554 | ||
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives | Q42585736 | ||
Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension | Q44506717 | ||
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease | Q45346653 | ||
Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. | Q45392148 | ||
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors | Q46370436 | ||
Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis | Q47279523 | ||
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience | Q47621106 | ||
Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. | Q51532468 | ||
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis | Q61763027 | ||
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation | Q79846807 | ||
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis | Q83803280 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | portal hypertension | Q124604 |
meta-analysis | Q815382 | ||
systematic review | Q1504425 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 34-41 | |
P577 | publication date | 2017-03-01 | |
2017-03-07 | |||
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis | |
P478 | volume | 23 |
Q87850418 | Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials |
Q91809509 | Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis |
Q88955825 | Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis |
Q54227364 | Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways. |
Q47296990 | Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study |
Q58125434 | Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score |
Q92362042 | Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization |
Q55278061 | Managing portal hypertension in patients with liver cirrhosis. |
Q90459409 | Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives |
Q94467538 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
Q39429850 | Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon |
Q92156002 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals |
Q47104014 | Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis |
Q46255835 | Prospective Validation of Intra- and Interobserver Reproducibility of a New Point Shear Wave Elastographic Technique for Assessing Liver Stiffness in Patients with Chronic Liver Disease |
Q88288515 | Reply to "Letter to Editor submitted by Rui Huang et al. entitled potential clinical application of strain elastography in chronic liver diseases" |
Q55363090 | Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension. |
Q41846141 | Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension? |
Search more.